4.7 Review

Emerging Genotype-Phenotype Relationships in Primary Ciliary Dyskinesia

Journal

Publisher

MDPI
DOI: 10.3390/ijms22158272

Keywords

primary ciliary dyskinesia; molecular genetics; genotype-phenotype association

Funding

  1. National Institutes of Health (NIH) [HL096458, HL116211, HL125241, AI46999]
  2. National Health and Medical Research Council [NHMRC1043768]
  3. Parion Sciences
  4. Aerocrine Pharmaceuticals
  5. National Center for Advancing Translational Sciences (NCATS) Rare Diseases Clinical Research Network (RDCRN) [U54HL096458]
  6. RDCRN Data Management and Coordinating Center (DMCC) [U2CTR002818]
  7. NCATS
  8. National Heart, Lung, and Blood Institute (NHLBI)

Ask authors/readers for more resources

PCD is a rare inherited condition affecting motile cilia and leading to organ laterality defects, recurrent infections, bronchiectasis, and severe lung disease. Research has shown variability in clinical presentations and relationships between genotype and phenotype. Advancements in genetic testing continue to redefine these relationships and uncover previously unrecognized milder forms of the disease.
Primary ciliary dyskinesia (PCD) is a rare inherited condition affecting motile cilia and leading to organ laterality defects, recurrent sino-pulmonary infections, bronchiectasis, and severe lung disease. Research over the past twenty years has revealed variability in clinical presentations, ranging from mild to more severe phenotypes. Genotype and phenotype relationships have emerged. The increasing availability of genetic panels for PCD continue to redefine these genotype-phenotype relationships and reveal milder forms of disease that had previously gone unrecognized.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available